Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.
about
Management of intracerebral hemorrhage--use of statinsAnti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer's Disease and Cerebral Amyloid AngiopathyFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsAnti-dementia medications: current prescriptions in clinical practice and new agents in progressImmunotherapy for Alzheimer's disease: hoops and hurdlesCombotherapy and current concepts as well as future strategies for the treatment of Alzheimer's diseaseGenetic heterogeneity in Alzheimer disease and implications for treatment strategiesCrystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumabThe antibody aducanumab reduces Aβ plaques in Alzheimer’s diseaseImmunotherapeutic approaches for Alzheimer's diseaseAPOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspectiveNeuroinflammation in Alzheimer's diseaseBapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapyAn anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 miceSample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.DBA/2J genetic background exacerbates spontaneous lethal seizures but lessens amyloid deposition in a mouse model of Alzheimer's disease.Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease.White matter changes in dementia: role of impaired drainage of interstitial fluid.Imaging endpoints for clinical trials in Alzheimer's disease.Cerebral amyloid angiopathy: emerging conceptsMagnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2Structural Neuroimaging of the Medial Temporal Lobe in Alzheimer's Disease Clinical Trials.First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer's disease.Future Directions in Imaging Neurodegeneration.Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients.Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study.Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloidDo current therapeutic anti-Aβ antibodies for Alzheimer's disease engage the target?Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease.Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer's disease.Novel immunological approaches for the treatment of Alzheimer's disease.An MRI rating scale for amyloid-related imaging abnormalities with edema or effusion.Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?Clustering of transcriptional profiles identifies changes to insulin signaling as an early event in a mouse model of Alzheimer's disease.Specific amyloid β clearance by a catalytic antibody construct.Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's disease
P2860
Q26752952-EA8C9504-A0DE-4FE0-8878-6EDABBDDDACEQ26781451-EA3561ED-D191-4263-B9A2-E4F926A493B0Q26784569-2C70CFA1-A2E5-4FA1-8825-776A5E426427Q26795400-AD2314D8-A802-4ABB-B317-414CA9E5F3A7Q26823877-7DDF8ACB-87CE-46ED-AAEC-14E32B9C3880Q26829899-52AE2F7A-FEBC-4093-8E52-0ADB46332D5FQ26995802-9A1C95B0-7CD8-4A8C-83C4-39A5341AE5C6Q27684692-FF7037AA-3098-4107-B720-6EFA9381C961Q28005463-D5AE93C5-C3A4-4021-A5F3-5B1F5572AEB1Q28081278-2AA07AEF-B2FA-446F-B8B8-D7BC4D7FF338Q28085213-73C58AB2-EFC6-46D3-9D1E-C6937231CA44Q28259238-41229C3C-9980-4B73-9C07-60B7A1293456Q28488690-37C9ADAB-70FD-4C26-B8C7-1D5E700669E9Q30316057-868EC454-3E26-45B5-B08B-736E3E37583AQ30354417-584C64F5-A4EC-4342-A131-A98F21072C76Q30412535-A65D490C-7323-4387-A637-79613012636AQ30651551-334E7BD8-64ED-4E76-9E61-38F7B5A4A1F8Q30880445-9439C8CE-5A3D-4314-9BA3-3F9EE932A76AQ30885979-4722281D-D723-4408-AFCE-E4C19C232AE4Q30894798-69B9F712-0C56-48CC-B2D1-509942A523DDQ30981669-A94534E7-4B46-449F-B690-13BCB51F26F1Q30996733-ACDEA7F5-DBBF-4143-AE8F-393A1E9BCFD5Q31050126-83894E89-3D26-4230-BA53-7883A99A5909Q31162702-CA7096C6-0BFD-40B8-BEA3-67ED70A3FEABQ31171988-9A33A014-8EE7-4A34-AEBF-E828416A0137Q33723082-02FF1F89-227E-4306-A0C3-C5C00FCC57F5Q33972726-D5ED1B9D-5BFF-4EA8-A838-FC8E23132EFCQ34154830-9776D436-A0F5-4661-9E44-D2784829264AQ34157492-11639C72-338A-4E26-9348-AD8D9597839DQ34286389-1592A0EB-9D29-43FA-8D75-2E39D437B75AQ34419108-F6945905-CC50-4664-9747-7EA83729DFC4Q34431008-67213E34-5391-4FB7-A898-338A743AE582Q34528767-71C32716-0DE7-49A9-9F67-380F0A4EC072Q34538592-BB4B8DF5-3C3B-4672-8E18-30394E6D12D1Q34562675-7CF4811E-2624-46C5-A64E-03BDFC4912CAQ34597563-8ACB89C8-D2DE-491A-826F-7939A1D153F2Q34629872-319FCADB-9B4F-4915-A391-C4FA42760310Q35052443-17ED5016-6F6C-40BD-8F4E-68084E0D5F20Q35451085-E6A5223E-B840-44DF-AE3F-CF6B1F92C8ECQ35540628-15B82AFC-38D3-48D8-8ADC-72D333858B7B
P2860
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Amyloid-related imaging abnorm ...... mab: a retrospective analysis.
@ast
Amyloid-related imaging abnorm ...... mab: a retrospective analysis.
@en
type
label
Amyloid-related imaging abnorm ...... mab: a retrospective analysis.
@ast
Amyloid-related imaging abnorm ...... mab: a retrospective analysis.
@en
prefLabel
Amyloid-related imaging abnorm ...... mab: a retrospective analysis.
@ast
Amyloid-related imaging abnorm ...... mab: a retrospective analysis.
@en
P2093
P2860
P50
P1433
P1476
Amyloid-related imaging abnorm ...... mab: a retrospective analysis.
@en
P2093
Anton P Porsteinsson
Donatella Tampieri
Gene G Kinney
H Michael Arrighi
H Robert Brashear
Ivan Lieberburg
Jerome Barakos
Keith M Gregg
Kristen A Morris
P2860
P304
P356
10.1016/S1474-4422(12)70015-7
P577
2012-02-03T00:00:00Z